View
How Real-World Clinico-Genomic Data is Delivering New Cancer Insights
Real-world clinico-genomic data is recognized across the healthcare community as a catalyst to spur potentially life-changing advancements in care and has become instrumental in our joint work to improve outcomes for patients with cancer. By analyzing this data, we can zoom in on niche patient populations to answer questions such as how patients with specific genomic signatures respond to a given treatment.
Updates From Foundation Medicine
Recent Research
-
April 05, 2022
Leveraging existing data to identify ancestry-associated features across multiple cancers
-
April 05, 2022
Development of a pan-cancer algorithm to predict homologous recombination deficiency and sensitivity to PARPi therapy
From the Foundation Forward Blog
-
March 30, 2022
Celebrating Women’s History Month: A Q&A with Foundation Medicine’s CMO, Mia Levy, MD, PhD
-
March 17, 2022
Companion Diagnostics Explained: Their Critical Role in Cancer Care and Our Latest Approvals | Foundation Medicine
-
February 23, 2022
What’s Next With Priti Hegde: How can immuno-oncology innovation transform care for cancer patients?
-
December 01, 2021
Finding Answers, Empowering Action
-
September 17, 2021
How Real-World Clinico-Genomic Data is Delivering New Cancer Insights | Foundation Medicine